Actively Recruiting
Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
Led by Our Lady of the Lake Hospital · Updated on 2025-03-20
20
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
EGFR gene mutations are some of the most commonly occurring mutations in non-small cell lung cancer. Investigators have developed a DNA instability model that estimates a risk score to assess the likelihood of an individual acquiring a cancer-linked mutation. The aim of this study is to collect blood from both those diagnosed with EGFR positive lung cancer and healthy individuals, evaluate their gene sequence surrounding the EGFR landscape and use the cancer positive and healthy sequences to validate the risk assessment model, which may one day be used to provide insight on susceptibility of getting EGFR positive lung cancer or potentially other cancer types.
CONDITIONS
Official Title
Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be between 18 and 100 years old
- Participants must be biologically female
- Participants diagnosed with EGFR positive lung cancer (Cancer group)
- Participants without a cancer diagnosis (Healthy control group)
You will not qualify if you...
- Participants younger than 18 years old
- Participants biologically male
- Participants who are incarcerated at the time of participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, United States, 70808
Actively Recruiting
Research Team
C
Cynthia Knox, MBA
CONTACT
C
Christine LeBoeuf, DNP
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here